看多

OPGN Idea

130
Might be time to revisit OPGN, Chart loos great and company should be expecting FDA approval
of their product relatively soon from what I'm reading.
All JMO please DYODD. I am NOT a financial advisor.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。